Skip to main content

Table 2 Revascularization and drug therapy during follow-up

From: Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

Therapy, n (%) All patients (n = 400)
β-blockers 358 (89.5)
Angiotensin-convertingenzyme 328 (82.1)
Calcium channel blocker 278 (69.5)
Diuretics 168 (42)
Nitrates 350 (87.4)
Aspirin 351 (87.8)
Heparin 400 (100)
Clopidogrel 314 (78.5)
Statins 400 (100)
Thrombolysis 24 (6.1)
Percutaneous coronary intervention 196 (49.1)